{
  "context": {
    "rules": [
      "Rule1: If a temperature excursion is recorded in the storage unit, then either the accelerated aging test passed for the formulation or the stability test did not fail for the formulation.",
      "Rule2: A temperature excursion is recorded in the storage unit or a humidity excursion is recorded in the storage unit.",
      "Rule3: Whenever the batch is released for distribution, the production batch meets specifications.",
      "Rule4: Under the condition that the packaging is approved for the batch, the labeling is approved for the batch.",
      "Rule5: Either an alternative packaging source is available from the supplier, or if the labeling is approved for the batch, then the batch is released for distribution.",
      "Rule6: Whenever the batch is approved for export, it complies with international regulations.",
      "Rule7: Under the condition that the production batch meets specifications, the drug formulation is approved.",
      "Rule8: If international regulations are complied with by the batch, then customs clearance is obtained for the batch.",
      "Rule9: If shipping arrangements are finalized for the batch, then export documentation is completed for the batch.",
      "Rule10: Provided that a supply chain disruption occurs for the material, either a backup supplier is available from the vendor or, if contamination is detected in the raw material, the raw material is rejected.",
      "Rule11: If a transportation delay occurs for the shipment, then either a backup supplier is available from the vendor or, provided that contamination is detected in the raw material, the raw material is rejected.",
      "Rule12: Whenever the vendor is evaluated and approved, a supply chain disruption occurs for the material.",
      "Rule13: Either the vendor is evaluated and approved or a logistics partner is selected as the carrier.",
      "Rule14: Provided that contamination is detected in the raw material, it is not the case that the raw material is rejected.",
      "Rule15: Either contamination is detected in the raw material or, if a regulatory inspection does not occur at the facility, then the production batch meets specifications.",
      "Rule16: Either a risk assessment is completed for the supply chain or the contingency plan is activated for the procedure.",
      "Rule17: Provided that the contingency plan is activated for the procedure, if it is not the case that whenever a logistics partner is selected as the carrier, a transportation delay occurs for the shipment, then emergency procurement is initiated for the material.",
      "Rule18: If a quality audit is scheduled for the facility, then if a risk assessment is completed for the supply chain, then whenever it is not the case that selecting a logistics partner as the carrier implies a transportation delay occurs for the shipment, emergency procurement is initiated for the material.",
      "Rule19: Under the condition that quarantine is initiated for the batch, the manufacturing process is completed for the batch.",
      "Rule20: Either quarantine is initiated for the batch or contamination is not detected in the raw material.",
      "Rule21: Either regulatory approval is received for the drug or quarantine is not initiated for the batch.",
      "Rule22: If sterilization is completed for the equipment, then whenever quarantine is initiated for the batch, the manufacturing process is not completed for the batch.",
      "Rule23: If it is not the case that if a humidity excursion is recorded in the storage unit, then either the accelerated aging test passed for the formulation or the stability test did not fail for the formulation, then the formulation is modified with a new excipient.",
      "Rule24: Provided that it is not the case that obtaining customs clearance for the batch implies the production batch meets specifications, then shipping arrangements are finalized for the batch.",
      "Rule25: If it is not the case that if customs clearance is obtained for the batch, then the production batch meets specifications, then it is not the case that export documentation is completed for the batch.",
      "Rule26: If it is not the case that whenever it is not the case that if the quality control test is passed by the batch, then sterilization is completed for the equipment, an investigation is initiated for the anomaly, then the stability test failed for the formulation.",
      "Rule27: Under the condition that a regulatory inspection does not occur at the facility, the packaging is approved for the batch.",
      "Rule28: If a regulatory inspection does not occur at the facility, then the batch is approved for export.",
      "Rule29: Provided that a regulatory inspection does not occur at the facility, it is not the case that the drug formulation is approved."
    ],
    "facts": [
      "Fact1: A quality audit is scheduled for the facility.",
      "Fact2: The quality control test is passed by the batch.",
      "Fact3: It is not the case that the accelerated aging test passed for the formulation.",
      "Fact4: It is not the case that the formulation is modified with a new excipient.",
      "Fact5: It is not the case that an alternative packaging source is available from the supplier.",
      "Fact6: It is not the case that a backup supplier is available from the vendor.",
      "Fact7: It is not the case that emergency procurement is initiated for the material.",
      "Fact8: It is not the case that regulatory approval is received for the drug.",
      "Fact9: It is not the case that an investigation is initiated for the anomaly."
    ]
  },
  "question": "A regulatory inspection occurs at the facility."
}